Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San Diego

University of California San Diego

Status: Unknown

Conditions: Hepatitis C, Chronic; Hepatitis C; HIV/AIDS

Study type: Observational

Funder types: Other

Identifiers

NCT03551002

171954 (Other Identifier)

IN-US-334-4481

Details and patient eligibility

About

A retrospective and prospective study among people living with HIV (PLWH) that assesses hepatitis C (HCV) treatment uptake during periods before and after direct acting antivirals (DAA) introduction, and its impact on the HCV epidemic among PLWH.

Full description

A study that aims to quantify the state of DAA uptake and its impact on the HCV epidemic among PLWH in San Diego, and to characterize negative predictors of DAA treatment uptake among PLWH in San Diego. Retrospective and prospective data from UCSD Owen Clinic will be utilized to calculate HCV prevalence, primary incidence, and reinfection incidence. Using mathematical epidemic models, the study will assess levels of existing and scaled-up interventions necessary for HCV elimination from PLWH in San Diego.

Enrollment: 450 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Any adult (≥ 18 years) HIV-infected patient attending the UCSD Owen Clinic
• With history of acute or chronic HCV infection defined as having a detectable HCV viral load with or without a positive HCV antibody

Exclusion criteria

• With no history of or current HCV infection defined as having a negative HCV antibody from 2008 to 2020

Trial design

450 participants in 2 patient groups

Retrospective

Prospective